Through microdialysis, they found increased endostatin and MMP-2 and MMP-9 levels in mice with breast cancer treated with tamoxifen, and inhibition of MMP-2 and MMP-9 resulted in a significant decrease in endostatin levels. Here, COL18A1 is linked to breast carcinoma.